Skip Ribbon Commands
Skip to main content
Sign In
Skip to main content Open accessibility information page

Board of Pharmacy

​​​​​​

Inquiries about the Board may be forwarded to

Anthony Rubinaccio
Executive Director
P.O. Box 45013
Newark, New Jersey 07101
Directions

Schedule an Appointment

To schedule an appointment to speak with Board staff in person at 124 Halsey Street, Newark, NJ
please click here.

ALERT

Removal of DATA-Waiver (“X” Waiver) Requirement

On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the "DATA-Waiver Program."  Pharmacists should be aware of the following changes, which are now in effect:

  • A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder.
  • All prescriptions for buprenorphine only require a standard DEA registration number. The previously used DATA-Waiver registration numbers are no longer needed for any prescription.  Pharmacists are reminded to use their professional judgement in determining if the prescription is within the scope of practice of the practitioner, as described in N.J.A.C.13:39-7.13.
    • There are no longer any limits or patient caps on the number of patients a prescriber may treat for opioid use disorder with buprenorphine.
    • The Act does not impact existing state laws or regulations that may be applicable.

    Separately, the Act also introduced new training requirements for all prescribers. These requirements will not go into effect until June 27, 2023, and can be found on the "DEA Resource Page" link in the Additional Information section below. 

    Further guidance will be forthcoming from the Board if necessary.

    For information regarding DEA's Diversion Control Division, please visit https://www.DEAdiversion.usdoj.gov or contact the Diversion Control Division Policy Section at ODLP@dea.gov.

     

    Additional information:



    ALERT

    Please note that all Pharmacy Technicians currently approved to immunize have had their Immunization Approval expiration dates extended until December 31, 2024. The website license verification function will reflect this extension.


    ALERT

    The Division of Consumer Affairs issued an alert to support health care practitioners in their efforts to protect patient data and information from disclosure. This alert, available here, identifies steps that practitioners can take to avoid collecting unnecessary data and to safeguard the data that they do collect and store.


    COVID-19 Emergency Graduate Licensure (njconsumeraffairs.gov)

    NOTICE OF EXTENSION OF TEMPORARY EMERGENCY GRADUATE LICENSURE PROGRAMS SUPERSEDING ALL PRIOR NOTICES

    EFFECTIVE DATE: July 15, 2022

    Effective immediately, the Division has determined that all temporary emergency graduate licensure programs will be continued until further notice. 

    Individuals currently holding TEGLs will remain authorized to practice under the TEGL, subject to the requirements set forth in AO 2020-05 and 2020-12

    The Division will continue to accept applications for TEGLs from recent graduates until further notice. 

    Click here to read the full notice and its impact on your temporary license.



    COVID-19 Immunization Administration by Health Care Practitioners-in-Training

    On February 19, 2021, the Acting Director of the Division of Consumer Affairs issued Administrative Order 2021-08 and Waiver 2021-04, which permits health care practitioners-in-training, which are students in medical schools or nursing programs, to administer a COVID-19 vaccine to patients upon direction from a supervising health care practitioner. The Order and Waiver defines a “supervising health care practitioner” as a doctor of medicine (M.D.), a doctor of osteopathic medicine (D.O.), a registered professional nurse (R.P.N.), an advanced practice nurse (A.P.N.), a physician assistant (P.A.), or a pharmacist (R.Ph.). The Order and Wavier requires a supervising health care practitioner to ensure that the health care practitioner-in-training has an attestation from a faculty member that attests that the health care practitioner-in-training is enrolled in an educational program, has completed the appropriate level of didactic education, and will have oversight while participating in a COVID-19 vaccinator program. The supervising health care practitioner also must ensure that the health care practitioner-in-training has completed CDC training in vaccination and is competent to administer a COVID-19 vaccine.

    Pharmacists should read and familiarize themselves with the provisions of this order.



    COVID-19 Immunization Administration by Certified Medical Assistant

    COVID-19 Immunization Administration by Additional Health Care Practitioners

    On February 19, 2021, the Acting Director of the Division of Consumer Affairs issued Administrative Order 2021-07 and Waiver 2021-03, which permits authorized health care personnel to administer a COVID-19 vaccine to patients upon direction from a supervising health care practitioner.  The Order and Waiver defines “authorized health care personnel” as “licensed practical nurses, certified homemaker home health aides, dentists, respiratory care therapists, perfusionists, podiatrists, optometrists, physical therapists, athletic trainers, and dental hygienists with local anesthesia permits.”  A “supervising health care practitioner” is defined as “a doctor of medicine (M.D.), a doctor of osteopathic medicine (D.O.), a registered professional nurse (R.P.N.), an advanced practice nurse (A.P.N.), a physician assistant (P.A.), or a pharmacist (R.Ph.).” The Order and Wavier requires a supervising health care practitioner to determine if authorized health care personnel are licensed in New Jersey and have been trained and are competent to administer a COVID-19 vaccine prior to directing authorized health care personnel to administer the vaccine. 

     

    Pharmacists should read and familiarize themselves with the provisions of this order.



    COVID-19 Immunization Administration by Certified Medical Assistant

    On February 19, 2021, the Acting Director of the Division of Consumer Affairs issued Administrative Order 2021-06 and Waiver 2021-02, which permits a certified medical assistant to administer a COVID-19 vaccine to patients upon direction from a supervising health care practitioner. The Order and Waiver defines a “supervising health care practitioner” as a doctor of medicine (M.D.), a doctor of osteopathic medicine (D.O.), a registered professional nurse (R.P.N.), an advanced practice nurse (A.P.N.), a physician assistant (P.A.), or a pharmacist (R.Ph.). The Order and Waiver waives provisions of N.J.A.C. 13:35-6.4 that limit CMAs to administering injections solely in physicians’ offices, mandate physicians to make determinations as to appropriateness of treatment, and prohibit CMAs from administering vaccines that have received Emergency Use Authorization but have not been approved by the United States Food and Drug Administration (FDA). The Order and Wavier requires a supervising health care practitioner to determine if a CMA is competent to administer a COVID-19 vaccine and to ensure that he CMA receives proper supervision when administering the vaccine.

    Pharmacists should read and familiarize themselves with the provisions of this order.



    Immunization Authority Expansion for Pharmacists, Interns, Externs and Pharmacy Technicians

    On January 5, 2021, the Director of the Division of Consumer Affairs issued four Administrative Orders which address administration of vaccinations and reporting requirements. The Administrative Orders are:

    • DCA-AO-2021-01, which permits licensed pharmacists to order and administer, and registered pharmacy interns and pharmacy externs to administer, FDA approved COVID vaccines to patients three years of age or older; 
    • DCA-AO-2021-02, which permits pharmacy technicians to administer childhood vaccines and related emergency medications, limited to diphenhydramine and epinephrine, to children three through seventeen years of age, and FDA approved COVID-19 vaccines to patients ages three and older;
    • DCA-AO-2021-03, which permits licensed pharmacists to order and administer, and registered pharmacy interns and pharmacy externs to administer, vaccines and related emergency medications, limited to diphenhydramine and epinephrine, to children three through seventeen years of age; and
    • DCA-AO-2021-04, which requires licensed health care providers who are authorized to administer vaccines to register and report to the NJIIS when administering a vaccine for COVID-19.

    Licensed pharmacists, registered pharmacy interns, pharmacy externs, and pharmacy technicians should read and familiarize themselves with the requirements of this order.



    The Board of Pharmacy, the oldest professional licensing board in New Jersey, was established in 1877 to protect the public by regulating the dispensing of prescription medications.

    The purpose of the Board is:

    • to protect the health, safety and welfare of the people of New Jersey; 
    • to regulate the practice of pharmacies and pharmacists.

    The Board protects the public by:

    • making sure that every pharmacist has met all of the necessary requirements for licensure;
    • investigating and disciplining any pharmacist who has not complied with the Board of Pharmacy's laws;
    • enforcing the requirement that every pharmacist continue his/her professional education and training to keep current with the evolving world of pharmacy;
    • requiring that all pharmacies be registered by the State and renew their permits annually;
    • ensuring that patients receive the prescribed medication.

    ​​​



    Last Modified: 9/24/2024 6:57 AM